8LJ-32480-11420
3 vaccinations
4 coded responses
45 check-ins
4 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 432 / OH
- Registered
- 2021-03-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-12
Registered in v-safe
-
2021-03-12
Dose 1 — Janssen/Johnson & Johnson
- 2021-03-12
- 2021-03-13
- 2021-03-14
- 2021-03-15
- 2021-03-16
- 2021-03-17
- 2021-03-18
- 2021-03-19
- 2021-03-26
- 2021-04-02
-
2021-04-09
Survey response — day 28, single doseMedDRA: Diarrhoea, Headache, Nausea, Pain — Feeling: Good · Be unable to do your normal daily activitiesFree text: A couple of days with Nausea, diarrhea, and general aches all over body, headache.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-16
- 2021-04-23
- 2021-06-11
- 2021-09-10
-
2021-10-30
Dose 2 — Pfizer-BioNTech
- 2021-10-31
- 2021-11-01
- 2021-11-02
-
2021-11-03
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Rash, not including the immediate area around the injection siteAdult check-in
-
2021-11-04
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Rash, not including the immediate area around the injection siteAdult check-in
-
2021-11-05
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Rash, not including the immediate area around the injection siteAdult check-in
- 2021-11-06
- 2021-11-13
-
2021-11-20
Survey response — day 21, dose 2MedDRA: Rash, Rash pruritic — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Taken 2 RX for prednisone second being higher dosage ( medrol pack). Rash diminishes slightly on prednisone, but reappears very itch after treatment. The rash appeared on October 31 a day after the Pfizer booster and is still present today 11/20/21.MedDRA releases: 2024-11 · check-in free text available
-
2021-11-20
Report sent to call center — day 21, dose 2Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-11-24
-
2021-11-24
Call successfulParticipant prefers to complete VAERS report online
-
2021-11-27
Survey response — day 28, dose 2MedDRA: Dermatitis allergic, Rash, Rash papular, Rash pruritic — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Raised rash continues to spread over entire body. Very itchy, raised areas. Have completed a report regarding Pfizer COVID allergic rash. Seeing allergy doctor 12/1/21MedDRA releases: 2024-11 · check-in free text available
-
2021-11-27
Report sent to call center — day 28, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-11-30
-
2021-12-04
Survey response — day 35, dose 2MedDRA: Office visit, Rash — Feeling: Fair · Get care from a doctor or other healthcare professionalFree text: Symptoms: Rash all over body continues · Healthcare visit (other): Allergist and dermatologistMedDRA releases: 2024-11 · check-in free text available
-
2021-12-04
Report sent to call center — day 35, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-12-07
Call successfulReported to VAERS voluntarily prior to GDIT contact
- 2021-12-11
- 2022-01-29
- 2022-04-30
-
2022-05-03
Dose 3 — Janssen/Johnson & Johnson
- 2022-05-03
- 2022-05-04
- 2022-05-05
- 2022-05-06
- 2022-05-07
- 2022-05-08
- 2022-05-09
- 2022-05-10
- 2022-05-17
- 2022-05-24
- 2022-05-31
- 2022-06-07
- 2022-06-14
- 2022-08-04
- 2022-11-04
- 2023-05-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-12 | Janssen/Johnson & Johnson | |
| 2 | 2021-10-30 | Pfizer-BioNTech | No |
| 3 | 2022-05-03 | Janssen/Johnson & Johnson | No |
Call center
3 call center cases
2 successful · 1 unsuccessful
VAERS report filed, before or during a call: 2
Free text
Release 7 — day 28, single dose
Symptoms: A couple of days with Nausea, diarrhea, and general aches all over body, headache.
Release 10 — day 21, dose 2
Symptoms: Taken 2 RX for prednisone second being higher dosage ( medrol pack). Rash diminishes slightly on prednisone, but reappears very itch after treatment. The rash appeared on October 31 a day after the Pfizer booster and is still present today 11/20/21. cut off by CDC
Release 10 — day 28, dose 2
Symptoms: Raised rash continues to spread over entire body. Very itchy, raised areas. Have completed a report regarding Pfizer COVID allergic rash. Seeing allergy doctor 12/1/21
Release 10 — day 35, dose 2
Symptoms: Rash all over body continues
Healthcare visit (other): Allergist and dermatologist
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Dermatitis allergic | · | · | ✓ |
| SD | Diarrhoea | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Pain | ✓ | ✓ | ✓ |
| SD | Rash | · | · | ✓ |
| SD | Rash papular | · | · | ✓ |
| SD | Rash pruritic | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release